MedPath

Effectiveness of Repeated MOTivational InterVention to Reduce Ethanol Intake During prEgnancy

Not Applicable
Conditions
Alcohol Abuse in Pregnancy
Interventions
Behavioral: Motivational interview
Registration Number
NCT04275570
Lead Sponsor
Fundació Sant Joan de Déu
Brief Summary

Ethanol exposure during pregnancy is associated with adverse perinatal outcomes resulting in high healthcare costs. Primary care centers whose attends low risk women will be randomized to apply a motivational intervention program to the mothers.

Detailed Description

This is a cluster randomized simple masking controlled trial evaluating the effectiveness of repeated motivational interview (MI) during pregnancy on prevalence of ethanol intake together with offspring´s neurodevelopment.

.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
600
Inclusion Criteria
  • Maternal age at recruitment > 18 years
  • Speak Spanish fluenty
  • Women controlling their pregnancy in Baix Llobregat Center and Hospital Sant Joan de Déu, who will attend their delivery in Hospital Sant Joan de Déu and Parc Sanitari Sant Joan de Déu
  • Viable singleton non- malformed fetus
  • First trimestre of gestation
Exclusion Criteria
  • Multiple gestations
  • Perinatal infections
  • Fetal anomalies including chromosomal anormalities or structural malformations detected by ultrasound
  • Premature rupture of membranes
  • Uncontrolled or/and severe maternal chronic disease
  • Language barriers
  • Imposibility to obtain the sample (hair lenght below nine centimeters)
  • Discolored hair
  • Refusal to join the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Motivational Interview.Motivational interviewRepeated motivational interview during prenatal care visits
Primary Outcome Measures
NameTimeMethod
Prevalence of ethanol intakeUp to 7 days from delivery

Biomarkers: Ethyl glucuronide in mother´s hair and phosphatidylethanol in cord blood

Secondary Outcome Measures
NameTimeMethod
Prenatal neurodevelopment: Corpus Callosum (CC) assesmentPregnancy (28 and 32 weeks of pregnancy)

Fetal neurosonography:

1. CC total area, measures in square centimeters (cm2)

2. CC's areas after a subdivision in 7 portions: rostrum, genu, rostral body, anterior midbody, posterior midbody, isthmus and splenium (cm2).

Prenatal neurodevelopment: Cortical development assessmentPregnancy (28 and 32 weeks of pregnancy)

Fetal neurosonography:

2. Cortical maturation grading (temporal area, Sylvian fissure, superior temporal sulcus ,frontal and parietal area and parieto-occipital sulcus, mesial area and cingulate sulcus and calcarine sulcus).

Trial Locations

Locations (2)

Centre d'Atenció a la Salut Sexual I Reproductiva of Baix Llobregat.

🇪🇸

Barcelona, Spain

Hospital Sant Joan de Déu

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath